New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- Efficacy of telotristat ethyl: A peripheral tryptophan hydroxylase inhibitor tha
- 1
- 4 years, 2 months ago
- The natural history of fibroblast growth factor receptor (FGFR)-altered cholangi
- 1
- 4 years, 2 months ago
- Comprehensive analysis of HER2 status through genomic, transcription, and transl
- 1
- 4 years, 2 months ago
- Identification of FGFR2/3 fusions from clinical cfDNA NGS using a de novo fusion
- 1
- 4 years, 2 months ago
- Epidemiology and patterns of care of intrahepatic cholangiocarcinoma (iCCA) in F
- 1
- 4 years, 2 months ago
- Pan-tumor analyses of kinase fusions detected in circulating tumor DNA (ctDNA) a
- 1
- 4 years, 2 months ago
- Comprehensive gene expression analysis of IDH1/2 mutant biliary cancers (BC).
- 1
- 4 years, 2 months ago
- Primary tumor (p-bx) versus metastatic tumor (m-bx) tissue versus liquid biopsy
- 1
- 4 years, 2 months ago
- Molecular targeted therapies: Ready for “prime time” in biliary tract cancer
- 1
- 4 years, 2 months ago
- Targeting CA 19-9 with a humanized monoclonal antibody at the time of surgery ma
- 1
- 4 years, 2 months ago
- The forum ‘New Developments’ is closed to new topics and replies.